Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults
JAMA Psychiatry · 01.06.2025 · 82 (6) · 555
DOI: 10.1001/jamapsychiatry.2025.0044 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift JAMA Psychiatry, erschienen am 01.06.2025. Verfasst von Lorenz Mueller und 11 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland. Hauptthemen laut MEDLINE: Attention Deficit Disorder with Hyperactivity, Lysergic Acid Diethylamide, Hallucinogens. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Microdosing psychedelics, including lysergic acid diethylamide (LSD), has gained attention for its potential benefits in several psychiatric disorders, including attention-deficit/hyperactivity disorder (ADHD). However, LSD’s efficacy in reducing ADHD symptoms remains unknown.
Objective
To determine the safety and efficacy of repeated low doses of LSD in reducing ADHD symptoms compared with placebo. Design, Setting, and Participants This was a 6-week, multicenter, double-blind, placebo-controlled, parallel-group phase 2A randomized clinical trial conducted between December 17, 2021, and December 4, 2023. Data were analyzed from March 22, 2024, to August 19, 2024. Outpatient treatment was provided at 2 centers: University Hospital in Basel, Switzerland, and Maastricht University in the Netherlands. Adults aged 18 to 65 years with a prior ADHD diagnosis who presented with moderate to severe symptoms (Adult Investigator Symptom Rating Scale [AISRS] score ≥26 and Clinical Global Impression Severity score ≥4) were eligible for inclusion. Key exclusion criteria included selected current major psychiatric or somatic disorders and the use of potentially interacting medications.
Intervention
Participants received either LSD (20 μg) or placebo twice weekly for 6 weeks (total of 12 doses). Main Outcome and Measures The primary outcome was the change in ADHD symptoms from baseline to week 6, assessed by the AISRS and analyzed with a mixed-effects model for repeated measures.
Results
A total of 53 participants were randomized to LSD (n = 27) or placebo (n = 26). Mean (SD) participant age was 37 (12) years, and 22 participants (42%) were female. The LSD group presented a mean AISRS improvement of −7.1 points (95% CI, −10.1 to −4.0). The placebo group presented a mean AISRS improvement of −8.9 points (95% CI, −12.0 to −5.8), with no difference between groups. LSD was physically safe and psychologically well tolerated overall. Conclusions and Relevance In this randomized clinical trial, repeated low-dose LSD administration was safe in an outpatient setting, but it was not more efficacious than placebo in reducing ADHD symptoms. Trial Registration ClinicalTrials.gov Identifier: NCT05200936
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Division of Clinical Pharmacology and Toxicology, University Hospital Basel, Basel, Switzerland.
- Department of Clinical Research, University of Basel, Basel, Switzerland.
- University Psychiatric Clinic Basel, Basel, Switzerland.
- Department of Biomedicine, University of Basel, Basel, Switzerland.
- Department of Neuropsychology and Psychopharmacology, Faculty of Psychology and Neuroscience, Maastricht University, Maastricht, the Netherlands.
Zitieren
APA
Mueller, L., Santos de Jesus, J., Schmid, Y., Müller, F., Becker, A., Klaiber, A., Straumann, I., Luethi, D., Haijen, E. C. H. M., Hurks, P. P. M., Kuypers, K. P. C., & Liechti, M. E. (2025). Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults. JAMA Psychiatry, 82(6), 555. https://doi.org/10.1001/jamapsychiatry.2025.0044
Vancouver
Mueller L, Santos de Jesus J, Schmid Y, Müller F, Becker A, Klaiber A, et al. Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults. JAMA Psychiatry. 2025;82(6):555. doi:10.1001/jamapsychiatry.2025.0044
BibTeX
@article{Mueller2025,
author = {Mueller, Lorenz and Santos de Jesus, Joyce and Schmid, Yasmin and Müller, Felix and Becker, Anna and Klaiber, Aaron and Straumann, Isabelle and Luethi, Dino and Haijen, Eline C H M and Hurks, Petra P M and Kuypers, Kim P C and Liechti, Matthias E},
title = {Safety and Efficacy of Repeated Low-Dose LSD for ADHD Treatment in Adults},
journal = {JAMA Psychiatry},
year = {2025},
volume = {82},
number = {6},
pages = {555},
doi = {10.1001/jamapsychiatry.2025.0044}
}
EUVIMED